Coronavirus is forcing us to confront addiction treatment paradoxes

On March 19th, the federal government  loosened regulations around methadone and buprenorphine, two medications used to treat opioid addiction. The change was triggered by the novel coronavirus and concerns that current practices would either contribute to its spread or restrict critical opioid addiction treatment. For all the havoc th e coronavirus is undoubtedly causing, it is also […]Find jobs at  Careers by KevinMD.com.  Search thousands of physician, PA, NP, and CRNA jobs now.  Learn more.

Source: Kevin, M.D. - Medical Weblog - April 7, 2020 Category: General Medicine Authors: < span itemprop="author" > < a href="https://www.kevinmd.com/blog/post-author/sara-k-schenk" rel="tag" > Sara K. Schenk, MD < /a > < /span > Tags: Conditions COVID-19 coronavirus Infectious Disease Psychiatry Source Type: blogs